v3.26.1
Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Total Hippo Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non controlling Interests
Beginning balance (in shares) at Dec. 31, 2024     24,866,803        
Beginning balance at Dec. 31, 2024 $ 365.2 $ 362.1 $ 0.0 $ 1,639.7 $ (2.7) $ (1,274.9) $ 3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (45.4) (47.7)       (47.7) 2.3
Other comprehensive income (loss) 2.1 2.1     2.1    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     290,411        
Issuance of common stock from stock plans and contingently issuable shares 1.0 1.0   1.0      
Shares withheld related to net share settlement (3.2) (3.2)   (3.2)      
Stock-based compensation expense 8.5 8.5   8.5      
Distributions to noncontrolling interests (2.5)           (2.5)
Ending balance (in shares) at Mar. 31, 2025     25,157,214        
Ending balance at Mar. 31, 2025 $ 325.7 322.8 $ 0.0 1,646.0 (0.6) (1,322.6) 2.9
Beginning balance (in shares) at Dec. 31, 2025 25,699,704   25,699,704        
Beginning balance at Dec. 31, 2025 $ 436.1 436.1 $ 0.0 1,651.5 1.8 (1,217.2) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7.1 7.1       7.1  
Other comprehensive income (loss) (2.4) (2.4)     (2.4)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     336,213        
Issuance of common stock from stock plans and contingently issuable shares 1.0 1.0   1.0      
Stock-based compensation expense $ 6.9 6.9   6.9      
Ending balance (in shares) at Mar. 31, 2026 26,035,917   26,035,917        
Ending balance at Mar. 31, 2026 $ 448.7 $ 448.7 $ 0.0 $ 1,659.4 $ (0.6) $ (1,210.1) $ 0.0